170 related articles for article (PubMed ID: 32622467)
1. Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis.
Suzuki Y; Liu S; Kadoya F; Takasaki Y; Yorozuya T; Mogi M
Br J Anaesth; 2020 Dec; 125(6):e446-e448. PubMed ID: 32622467
[No Abstract] [Full Text] [Related]
2. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
Front Immunol; 2021; 12():668962. PubMed ID: 34385999
[TBL] [Abstract][Full Text] [Related]
3. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
[TBL] [Abstract][Full Text] [Related]
4. Association between mutated Mas-related G-protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis. Comment on Br J Anaesth 2020; 125: e448-50.
Suzuki Y; Liu S; Kadoya F; Takasaki Y; Yorozuya T; Mogi M
Br J Anaesth; 2021 Jul; 127(1):e21-e22. PubMed ID: 33992399
[No Abstract] [Full Text] [Related]
5. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.
Suzuki Y; Liu S; Ogasawara T; Sawasaki T; Takasaki Y; Yorozuya T; Mogi M
Eur J Pharmacol; 2020 Jul; 878():173104. PubMed ID: 32320700
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report.
Choi SC; Han S; Kwak J; Lee JY
Korean J Anesthesiol; 2020 Aug; 73(4):342-346. PubMed ID: 31619026
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity.
Ebo DG; Van der Poorten ML; Elst J; Van Gasse AL; Mertens C; Bridts C; Garvey LH; Horiuchi T; Sabato V
Br J Anaesth; 2021 Jan; 126(1):e27-e29. PubMed ID: 33153719
[No Abstract] [Full Text] [Related]
8. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?
Van Gasse AL; Elst J; Bridts CH; Mertens C; Faber M; Hagendorens MM; De Clerck LS; Sabato V; Ebo DG
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):998-1003. PubMed ID: 30315997
[TBL] [Abstract][Full Text] [Related]
9. Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis. Comment on Br J Anaesth 2020; 125: e446-e448.
Elst J; Sabato V; Mertens C; Garvey LH; Ebo DG
Br J Anaesth; 2020 Dec; 125(6):e448-e450. PubMed ID: 33010928
[No Abstract] [Full Text] [Related]
10. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2).
Kumar M; Singh K; Duraisamy K; A Allam A; Ajarem J; Kwok Chong Chow B
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106575
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.
Aalberse RC; Kleine Budde I; Mulder M; Stapel SO; Paulij W; Leynadier F; Hollmann MW
Br J Anaesth; 2011 May; 106(5):665-74. PubMed ID: 21414980
[TBL] [Abstract][Full Text] [Related]
13. [Severe anaphylaxis associated with rocuronium administration].
Bermejo Alvarez MA; Carpintero M; Cosío F; Fervienza P; Castañón E
Rev Esp Anestesiol Reanim; 2004 Nov; 51(9):562-3. PubMed ID: 15620172
[No Abstract] [Full Text] [Related]
14. Histaminoid reactions associated with rocuronium.
Neal SM; Manthri PR; Gadiyar V; Wildsmith JA
Br J Anaesth; 2000 Jan; 84(1):108-11. PubMed ID: 10740560
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex and rocuronium-induced anaphylaxis.
Wordsworth HI; Raja Y; Harrison S
Br J Anaesth; 2011 Jun; 106(6):911-2. PubMed ID: 21576105
[No Abstract] [Full Text] [Related]
16. MRGPRX2 and Adverse Drug Reactions.
McNeil BD
Front Immunol; 2021; 12():676354. PubMed ID: 34421893
[TBL] [Abstract][Full Text] [Related]
17. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
18. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
19. Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
Zeng Y; Wang J; Zhang Y; Ge S; Wu Y; Fan T; Wang N
Cell Immunol; 2019 Jul; 341():103923. PubMed ID: 31076078
[TBL] [Abstract][Full Text] [Related]
20. Severe intraoperative anaphylactic reaction: aprotinin and rocuronium.
Santos Silva F
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):740-3. PubMed ID: 18922434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
